TruthArchive.ai - Related Video Feed

The speaker discusses the spread of bird flu and the potential for mass culling of poultry. They mention the development of bird flu vaccines and the possibility of human-to-human transmission. The conversation also touches on the lack of human trials for vaccines and the FDA's approval process based on preclinical data. The focus is on the need for vaccination, particularly for farm workers.

We have been studying epidemics for about forty years, particularly looking at the issue of legislation. Working with animals, such as chickens with bronchitis caused by coronavirus, has been somewhat simpler. Despite thirty years of trying various vaccines, we have not been able to control it effectively. So, why is it that we suddenly find a solution for humans when we have struggled to find one for the flu? How can we achieve this?

Research on potential pandemic pathogens, known as gain of function studies, has led to valuable public health insights. Previous NSABB reports support this. While I won't argue for the necessity of this research, there are many freely available studies showing how mutations identified through these studies have helped us prepare for epidemics and pandemics.

The world's perception of influenza needs to change in order to address the problem effectively. There is a possibility of a novel avian virus outbreak in China, which could have devastating consequences. If another pandemic were to occur, millions of people could die within a short period of time. Disruptive and iterative approaches are necessary to tackle this issue. The government has a role to play in pushing the industry to prioritize public health over profit. The perception of influenza is not as serious as other diseases, which makes it difficult to bring about change. Resources need to be allocated more efficiently during crises, and synthetic-based vaccines could revolutionize the field. The goal is to align different capabilities, funding streams, and incentives towards a common goal. More resources and financial incentives could attract new talent to the field.

Professor David Moranz discusses the concept of viral-bacterial co-pathogenesis and its relevance to sepsis, septic shock, and death from bacterial disease, using early 20th-century pandemics as a lens. Key points: - The idea that sepsis, septic shock, and death can be downstream events prompts examination of upstream events and progression to prevent outcomes. - Co-pathogenesis, involving simultaneous infection with a virus and a bacterium, was recognized in the early 1900s. Ellis Island health officers noted higher mortality in children with viral infections like measles when co-infected with bacteria such as streptococci or diphtheria. - During World War I, crowded army camps experienced massive measles outbreaks and secondary bacterial pneumonia deaths. A notable study tracked soldiers with measles: those who were colonized with group A beta-hemolytic streptococcus (Strep pyogenes) had all complications and deaths among colonized individuals, while non-colonized soldiers fared better. - With influenza in 1918, pathology from the Armed Forces Institute of Pathology showed that death was associated with severe bacterial pneumonia in all 58 autopsies studied. Across 173 autopsy studies from 15 countries (over 8,000 individuals), 95% had pneumopathogens cultured from the lungs; 80.4% of pleural effusions contained pneumopathogens; 70% of those with pre-death blood cultures had one or more positive cultures. - The principal pneumopathogens identified were Streptococcus pneumoniae (pneumococcus), Streptococcus pyogenes (Group A beta-hemolytic strep), and Staphylococcus, though other pathogens occurred as well, including meningococcus in some outbreaks of fatal influenza-associated pneumonia. - Pathology commonly showed bronchopneumonia, with viral lesions characterized by infection of apical cells of the bronchiolar and bronchial epithelium. The virus disrupts the protective epithelial layer, enabling bacteria to colonize the basal layer and cause pneumonia. This is why bronchopneumonia was prevalent in both measles- and influenza-associated deaths. - The proximate cause of death often involved hypoxia from damaged pulmonary tissue or alveolar edema; sepsis and multi-organ failure were also cited in some cases, alongside heart or renal failure in others. - Notable interpretation by contemporaries: French physician quote that influenza condemns secondary infections; William McCallum remarked he never autopsied a flu death without finding bacteria. He viewed these events as epidemics of severe bacterial pneumonia precipitated by the two viruses. - In modern research, experimental models (mostly mice, sometimes primates) show that adding influenza (or similar viruses) to a bacterial infection like pneumococcus results in markedly worse pathology and faster death, illustrating the continuing relevance of viral-bacterial co-pathogenesis. The talk links historical observations to current inquiry, describing how colonization by pneumopathogens in crowded settings, followed by a cytolytic viral infection that damages the respiratory epithelium, creates conditions for severe bacterial pneumonia and respiratory compromise.

We must remain vigilant about current diseases, but an even greater danger is focusing too much on the last pandemic when preparing for future threats. Emerging infections can arise from various sources, and we are still vulnerable to intentional spread by those seeking to cause harm. Our global community's health faces numerous potential threats. It's crucial to consider a wide range of possibilities to effectively safeguard public health.

The NIH is developing a universal vaccine that addresses the entire phylum of viruses. This vaccine mimics natural immunity and is effective against any kind of mutation. It doesn't drive the virus to mutate. The researchers believe it could be effective not only against coronaviruses but also against influenza. The vaccine is described as much safer and much more effective. The exchange then notes that Mark, did you take your question again? and Mark is prompted to ask his question.

The situation has been horrific, leading to a shift in research and development budgets. Current vaccines primarily focus on improving individual health but only slightly reduce transmission. There is a need for a new approach to vaccine development that effectively blocks transmission.

We are addressing real and critical threats related to a novel coronavirus called CAPS, which is similar to the viruses that caused the SARS epidemic and MERS outbreaks. We need to be prepared for a fast-moving and highly lethal pandemic of a respiratory pathogen. This disease is more transmissible than SARS or MERS and as contagious as influenza. The virus can be easily transmitted through the air, making everyone susceptible. Asymptomatic individuals can also spread the virus, leading to a severe pandemic that affects people worldwide. Many countries will be affected simultaneously.

It seems that bird flu, a gain-of-function strain, is causing concern. The strain possibly originated from the USDA Poultry Research Lab in Georgia. Former CDC director Redfield mentioned that manipulating the virus could make it transmissible to humans. Interestingly, the director of the lab has ties to the Gates Foundation. This raises questions about the origins and implications of the outbreak.

There is a lack of knowledge and organization regarding infectious diseases in this country, leading to panic and unreasonable plans. The fear of a highly contagious and deadly virus like avian flu caused unnecessary concern. However, the speaker explains that the flu cannot cause the same level of mortality as it did in the past due to various reasons. The contagiousness of respiratory diseases is limited, with each patient infecting an average of two people. The exaggerated response to these diseases, resembling a nuclear threat, should be managed by medical professionals rather than government agencies.

Bird flu could potentially lead to a pandemic that is much more severe than COVID-19. It's not a matter of if, but when this will happen. When bird flu infects humans, it has a high mortality rate, estimated between 25% and 50%. The situation becomes critical once the virus can attach to human receptors and spread from person to person. Given these factors, it is likely that we will face a bird flu pandemic in the future.

Evolution is random, but when a virus evolves naturally, it's through random mutation. However, when a virus is created in a lab, it's not random but man-made. Creating a virus in the lab to discover what could happen in nature is unlikely to result in a vaccine that helps. This controversy started in 2010 with the avian flu, which is deadly but not very contagious. A scientist in the Netherlands aerosolized it, causing a debate on whether the knowledge should be published due to potential misuse. Anthony Fauci supported publishing the knowledge, despite the risks. Government funding of gain of function research, which involves making viruses more dangerous, continued despite a pause from 2014 to '16. The culpability extends beyond Fauci to the government.

Research on bird flu in laboratories has raised significant concerns. At the Scripps Institute in California, funded by the Bill and Melinda Gates Foundation and NIH, scientists identified mutations that could enhance the virus's ability to infect humans, sharing their findings in the journal Science. Similarly, Yoshihiro Kawaoka at the University of Wisconsin has conducted gain-of-function research on bird flu for decades, experiencing multiple lab accidents with modified strains. In the Netherlands, Ron Fouchier at Erasmus Medical Center has been working on making bird flu airborne using ferrets. This ongoing research poses substantial risks, and there are calls to halt gain-of-function studies to prevent potential leaks and misuse of information.

In the future, there may be a deadly airborne disease. To effectively deal with it, we need to establish a global infrastructure that enables us to quickly detect, isolate, and respond to such outbreaks. By investing in this infrastructure now, we can be better prepared for future strains of flu, like the Spanish flu, that may emerge in the next five to ten years. It is a wise investment to make.

NIH is pursuing a universal vaccine designed to cover the entire range of viruses, aiming to mimic natural immunity. The developers claim it would be effective against any mutation and would not drive the virus to mutate. They expect the approach could work not only for coronaviruses but also for flu, offering broad protection. They describe the vaccine as safer and more effective than current options. The dialogue centers on ongoing questions as the project advances, emphasizing a shift toward a single, universal solution that could, if successful, provide cross-viral protection and reduce the need for virus-specific vaccines. The statements focus on safety, efficacy, and cross-coverage across coronaviruses and influenza.

If a highly infectious virus is to cause over 10 million deaths in the coming decades, it is likely due to a pandemic. Without proper preparedness, a new airborne outbreak could significantly impact millions. Future administrations will inevitably face challenges similar to those of their predecessors, making pandemic prevention a top priority. The current administration will confront its first major epidemic, potentially influenced by impulsive and fact-averse attitudes. The likelihood of another severe pandemic is high, as seen with the emergence of a new coronavirus. There is a possibility of a novel avian virus outbreak, which could lead to rapid vaccine development and self-administration.

In this video, the speaker discusses how certain strains of influenza are not included in PCR tests, such as the BSL 4 strain, h7n9, and h5n1. They question the effectiveness of testing millions of people without being able to detect these specific strains. The speaker also mentions Kristin Drosten and refers to this situation as an "evil genius" move.

In the future, there might be a deadly airborne disease. To effectively handle it, we need a global infrastructure that enables us to detect, isolate, and respond to it swiftly. This infrastructure should be in place not only in our country but worldwide. By investing in this infrastructure, we can be better prepared to tackle future outbreaks, such as a new strain of flu similar to the Spanish flu, that may emerge in the next five or ten years.

Scientists can learn how to teach the flu virus how to infect human tissue, and some are already doing this. The scientific community isn't trying to cause a pandemic, but they are arrogant about their ability to contain a respiratory pathogen. COVID evolved from scientific experiments in a laboratory that was trying to do good things, like make a vaccine vector, but it escaped, and over 20,000,000 people died. Nature will continue to try to change, but the species barrier for amino acids is pretty high. Some scientists believe gain of function research is needed to protect humanity against emerging pathogens, but they don't consider the fact that they may be emerging them like with COVID.

Vaccinating birds with a leaky vaccine, one that doesn't provide sterilizing immunity, turns the flocks into mutation factories, teaching the organism how to mutate. This destabilizes the organism and makes it more likely to jump to animals. The speaker claims that all agency heads from NIH, CDC, and FDA advised against bird vaccination because it is dangerous for human beings.

Researchers have been working on making bird flu more contagious for humans through gain of function research. The virus mainly infects chickens and sometimes cattle. Chinese vaccination efforts in the 90s may have worsened the situation. The current strain, H5N1 avian influenza, has caused around 800-900 human cases with a high mortality rate in Southeast Asia. Recent US cases were easily treated. The virus is not a significant threat unless it starts spreading human to human. The recent strain may have originated from experiments on mallard ducks in Georgia, leading to its spread across states. The media has not questioned this spread caused by migratory waterfowl.

We're discussing the urgent need for a better flu vaccine that can protect against all types of influenza viruses. To tackle this challenge, we require passionate and talented individuals from diverse backgrounds to collaborate. By combining unconventional thinking, we can find faster solutions. Unlike measles, which remains consistent over time, influenza constantly changes due to mutations. This means that a new vaccine is needed each year to match the circulating virus. Occasionally, there are major changes in the virus caused by mutations or when it jumps species, resulting in a unique situation. Other viral infections like polio, smallpox, and measles do not exhibit this level of variability.

If we ignore the problem of felons in the US, we'll face more issues like H5N2 bird flu. The alleged H5N, avian influenza, is available for sale on the BEI Resources website since 2016. The concern lies in gain of function research in labs, where the recipe to make bird flu highly infectious for humans is already known.

My understanding of the PC30 framework is that it focuses on a small number of viruses with both pathogenicity and transmissibility. However, there are discrepancies in the criteria used, leading to unintended studies being included. More refinement may be needed to ensure accurate submissions. The definition on paper may not always align with real-world practices.